EP0474676A4 - Production of ibdv vp2 in highly immunogenic form - Google Patents

Production of ibdv vp2 in highly immunogenic form

Info

Publication number: EP0474676A4
Authority: EP; European Patent Office
Prior art keywords: ibdv; production; highly immunogenic; immunogenic form; highly
Prior art date: 1989-05-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP19900908160

Other versions

EP0474676A1 (en

Inventor

Ahmed Abdulla Azad

Ian Geoffrey Macreadie

Neil Moreton Mckern

Paul Richard Vaughan

Mittur Nanjappa Jagadish

Kevin John Fahey

Antony James Chapman

Hans-Georg Heine

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Commonwealth Scientific and Industrial Research Organization CSIRO

Original Assignee

Commonwealth Scientific and Industrial Research Organization CSIRO

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-05-30

Filing date

1990-05-29

Publication date

1993-02-24

1990-05-29 Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO

1992-03-18 Publication of EP0474676A1 publication Critical patent/EP0474676A1/en

1993-02-24 Publication of EP0474676A4 publication Critical patent/EP0474676A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Chemistry (AREA)
Mycology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

EP19900908160 1989-05-30 1990-05-29 Production of ibdv vp2 in highly immunogenic form Withdrawn EP0474676A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
AUPJ446989		1989-05-30
AU4469/89		1989-05-30
AU57315/90A AU643216B2 (en)	1989-05-30	1990-05-29	Production of IBDV VP2 in highly immunogenic form

Publications (2)

Publication Number	Publication Date
EP0474676A1 EP0474676A1 (en)	1992-03-18
EP0474676A4 true EP0474676A4 (en)	1993-02-24

Family

ID=25631592

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP19900908160 Withdrawn EP0474676A4 (en)	1989-05-30	1990-05-29	Production of ibdv vp2 in highly immunogenic form

Country Status (3)

Country	Link
EP (1)	EP0474676A4 (en)
AU (1)	AU643216B2 (en)
WO (1)	WO1990015140A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7955591A (en) *	1990-05-04	1991-11-27	University Of Maryland At College Park, The	Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines
BE1004877A3 (en) *	1991-05-27	1993-02-16	Solvay	RECOMBINANT AVIPOX VIRUS, CULTURE OF CELLS INFECTED WITH THIS VIRUS AND POULTRY VACCINES DERIVED FROM THIS VIRUS.
US5788970A (en) *	1994-03-29	1998-08-04	The University Of Maryland College Park	Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
FR2751225B1 (en) *	1996-07-19	1998-11-27	Rhone Merieux	AVIAN POLYNUCLEOTIDE VACCINE FORMULA
WO2001092486A1 (en) *	2000-05-31	2001-12-06	Akzo Nobel N.V.	Serotype chimeric ibdv strains
AUPR546801A0 (en) *	2001-06-05	2001-06-28	Commonwealth Scientific And Industrial Research Organisation	Recombinant antibodies
MXPA06005424A (en)	2003-11-13	2007-01-25	Univ Georgia Res Found	Methods of characterizing infectious bursal disease virus.
DE102011121069A1 (en) *	2011-12-13	2013-06-13	Martin-Luther-Universität Halle-Wittenberg	Vaccination by recombinant yeast by generating a protective humoral immune response against defined antigens
CN114276420A (en) *	2021-10-28	2022-04-05	华南农业大学	A kind of preparation method of soluble VP2 antigen, vaccine and antigen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU587624B2 (en) *	1985-05-30	1989-08-24	Commonwealth Scientific And Industrial Research Organisation	Expression of host-protective immunogens of ibdv.
AU619477B2 (en) *	1987-06-26	1992-01-30	Commonwealth Scientific And Industrial Research Organisation	Ibdv vp2 epitope recognised by virus neutralising and protective monoclonal antibodies

1990
- 1990-05-29 EP EP19900908160 patent/EP0474676A4/en not_active Withdrawn
- 1990-05-29 AU AU57315/90A patent/AU643216B2/en not_active Ceased
- 1990-05-29 WO PCT/AU1990/000224 patent/WO1990015140A1/en not_active Application Discontinuation

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF GENERAL VIROLOGY, vol. 70, 1989, GB; K.J. FAHEY et al., pp. 1473-1481 *
JOURNAL OF GENERAL VIROLOGY, vol. 71, 1990; F.S.B. KIBENGE et al., pp. 569-577 *
JOURNAL OF THE CHINESE SOCIETY OF VET. SCIENCE, vol. 13, 1987; L.H. LEE et al., pp. 99-108 *
See also references of WO9015140A1 *
VIROLOGY, vol. 143, 1985; A.A. AZAD et al., pp. 35-44 *
VIROLOGY, vol. 161, 1987; A.A. AZAD et al., pp. 145-152 *

Also Published As

Publication number	Publication date
AU5731590A (en)	1991-01-07
AU643216B2 (en)	1993-11-11
WO1990015140A1 (en)	1990-12-13
EP0474676A1 (en)	1992-03-18

Publication	Publication Date	Title
GB2189150B (en)	1990-02-14	Prosthesis and process for its manufacture
ZA852724B (en)	1985-11-27	Multivalent pneumococcal vaccine and preparation thereof
GB8924438D0 (en)	1989-12-20	Vaccine composition
EP0406440A4 (en)	1991-05-08	Production of polyether
EP0256561A3 (en)	1989-07-12	Sweet and process for its preparation
ZA90474B (en)	1990-10-31	Vaccine composition
IL90312A (en)	1993-01-31	Preparation of perfluoropolyethers
GR890100817A (en)	1991-03-15	Purfines preparation process
IL96306A0 (en)	1991-08-16	Preparation of deoxyfluoronucleosides
EP0474676A4 (en)	1993-02-24	Production of ibdv vp2 in highly immunogenic form
GB2194155B (en)	1990-07-04	Improvements in prostheses
LTIP1406A (en)	1995-05-25	Edulcorant and its preparation process
IL85944A0 (en)	1988-09-30	5-pyrazinyl-1,3,4-oxadiazole and thia-diazole derivatives their preparation and their use as nematicides
AP9000165A0 (en)	1990-04-30	Vaccine composition
ZA876598B (en)	1988-03-14	Bromofluoroethylhypofluorite and process for its preparation
IL81920A0 (en)	1987-10-20	Vaccines and their preparation
GB2234254B (en)	1992-12-02	Methylpolysilanes having controllable rheology and method for their preparation
EP0408332A3 (en)	1991-07-03	Natural fermentation agent
GB2248186B (en)	1993-04-28	Preparation of vaccines
GB8711988D0 (en)	1987-06-24	Combined sequencer & inserter machine
EP0416577A3 (en)	1993-02-24	Method of preparing levoglucosenone
GB2187737B (en)	1990-03-14	Preparation of 2,6-dihalo-4-cyanophenol esters
HU204708B (en)	1992-02-28	Process for producing tea blend having high consumption value and medicinal effect
HU198072B (en)	1989-07-28	Process for producing tetrahydrobenzothiazoloquinolines and pharmaceutical compositions comprising same
GB8726750D0 (en)	1987-12-23	Artificial & natural structures

Legal Events

Date	Code	Title	Description
1992-01-31	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1992-03-18	17P	Request for examination filed	Effective date: 19910919
1992-03-18	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE
1993-02-24	A4	Supplementary search report drawn up and despatched	Effective date: 19930108
1993-02-24	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE
1994-01-12	17Q	First examination report despatched	Effective date: 19931201
1994-05-11	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH OR
1998-10-16	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
1998-12-02	18D	Application deemed to be withdrawn	Effective date: 19980610